cytarabine has been researched along with fluorescein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belch, AR; Gati, WP; Larratt, LM; Paterson, AR; Turner, AR | 1 |
| Andersson, C; Blom, K; Eriksson, A; Gustafsson, MG; Haglund, C; Höglund, M; Kashif, M; Larsson, R; Österroos, A | 1 |
2 other study(ies) available for cytarabine and fluorescein
| Article | Year |
|---|---|
Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
Topics: Acute Disease; Adenosine; Affinity Labels; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Death; Cytarabine; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Leukemia; Nucleosides; Thionucleosides; Tumor Cells, Cultured | 1997 |
Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fluorescein; Fluorescent Dyes; Heterocyclic Compounds, 4 or More Rings; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Male; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Small Molecule Libraries; Spectrometry, Fluorescence; Tetrazoles; Tumor Cells, Cultured | 2016 |